Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis-Reference-Cited by-同舟云学术

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

Published:2016-01-07 Issue:5 Volume:10 Page:607-618
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Jairath Vipul,Zou Guangyong,Parker Claire E.,Macdonald John K.,Mosli Mahmoud H.,Khanna Reena,Shackelton Lisa M.,Vandervoort Margaret K.,AlAmeel Turki,Al Beshir Mohammad,AlMadi Majid,Al-Taweel Talal,Atkinson Nathan S. S.,Biswas Sujata,Chapman Thomas P.,Dulai Parambir S.,Glaire Mark A.,Hoekman Daniel,Koutsoumpas Andreas,Minas Elizabeth,Samaan Mark A.,Travis Simon,D’Haens Geert,Levesque Barrett G.,Sandborn William J.,Feagan Brian G.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/5/607/13746445/jjw004.pdf

Reference71 articles.

1. Treatment effects and placebo effects

2. The placebo response in medicine: minimize, maximize or personalize?

3. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

4. The placebo response in clinical trials: more questions than answers

5. A Meta-Analysis of the Placebo Rates of Remission and Response in Clinical Trials of Active Ulcerative Colitis

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study;Inflammation and Regeneration;2024-04-25

2. Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants;Crohn's & Colitis 360;2024-03-15

3. Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: An open-label, proof-of concept study;2024-02-28

4. A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score;Clinical and Translational Science;2023-09-22

5. Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis;Inflammatory Bowel Diseases;2023-04-01